Compositions and methods of treating facioscapulohumeral muscular dystrophy
US12071485B2 · kind B2 · utility
0Cited by
106References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 2, 2024 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Jan 2, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.